These findings suggest that the antiapoptotic mechanisms of Venetoclax-resistant cells have transitioned from BCL-2-dependent to MCL-1- and/or BCL-xl dependent, especially MCL-1, which prevents BCL-2 inhibitors from inducing tumor cell apoptosis. Here, BCL2 is linked to neoplasm.